Tet Agreement

Mountain View, CA and Heidelberg Germany -July 26, 2010-Clontech Laboratories, Inc., a wholly owned subsidiary of Takara Bio Inc., and TET Systems (TET), a private German biotechnology company based in Heidelberg, announced today that they have signed an amendment to their existing licensing agreement. Under the expanded licensing agreement, Clontech obtains the rights to develop, manufacture and market new Tet Systems products as Tet-On® 3G™ Inducible Expression System (www.clontech.com/teton3g). After the consequences of Tset, President Johnson was attacked from all sides because of his policy towards Vietnam. General Westmoreland asked for an additional 200,000 troops to subdue the Communists, and a national riot broke out after that request was made public, forcing Johnson to recall Westmoreland to Washington. On March 31, Johnson announced that the United States would begin de-escalation in Vietnam, stop bombing North Vietnam and seek a peace agreement to end the conflict. In the same speech, he also announced that he would not run for re-election as president, stressing his responsibility for the creation of the Vietnamese national division. “We are pleased to have signed this agreement with PC Project and hope that the use of our proprietary technology will help the PC project and its affiliated researchers improve the situation of patients with this disease,” said Dr. Ernst Bohnlein, Executive Director of TET Systems. “We were not aware of this very rare genetic disease before, and we decided to support research on PC projects not only through access to Tet technology, but also to directly support the great reason for PC projects, to raise awareness of PCs and to find treatments.” TET Systems Holding GmbH – Co.

KG (“TET Systems”), the world leader in controlled gene expression, announced today that TET Systems and Novo Nordisk A/S have signed a licensing agreement that allows the Hagedorn Research Institute (HRI), a research institute within Novo Nordisk A/S, to use Tet technology for its internal research activities. “We are very pleased to welcome the RIKEN BioResource Center into our growing family partner.

Comments are closed